Our results indicate that T-DM1 inhibited cell proliferation and induced apoptosis in NSCLC cells with endogenous or acquired high HER-2 levels but its activity does not seem to be related to HER-2 mutational status. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.